Essential Site Maintenance: Authorea-powered sites will be updated circa 15:00-17:00 Eastern on Tuesday 5 November.
There should be no interruption to normal services, but please contact us at [email protected] in case you face any issues.

loading page

The Metabolite Vanillic Acid Regulates Acinetobacter baumannii Surface Attachment
  • +2
  • Veronica G. Godoy,
  • Merlin Brychcy,
  • Brian Nguyen,
  • Pranav Casula,
  • Alexis Kokodynski
Veronica G. Godoy
Northeastern University

Corresponding Author:[email protected]

Author Profile
Merlin Brychcy
Northeastern University
Author Profile
Brian Nguyen
Northeastern University
Author Profile
Pranav Casula
Northeastern University
Author Profile
Alexis Kokodynski
Northeastern University
Author Profile

Abstract

The nosocomial bacterium Acinetobacter baumannii is protected from antibiotic treatment by acquiring antibiotic resistances and by forming biofilms. Cell attachment, one of the first steps in biofilm formation, is normally induced by environmental metabolites. We hypothesized that vanillic acid, the oxidized form of vanillin, a widely available metabolite with antimicrobial properties, may play a role in A. baumannii cell attachment. We first discovered that A. baumannii actively breaks down VA through the evolutionarily conserved vanABKP genes. These genes are under the control of the repressor VanR, which we show binds directly to VanR binding sites within the vanABKP genes bidirectional promoter. VA in turn counteracts VanR inhibition. We identified a VanR binding site and searched for it throughout the genome especially in pili encoding promoter genes. We found a VanR binding site in the pilus encoding csu operon promoter and showed that VanR binds specifically to it. As expected, a strain lacking VanR overproduces Csu pili and makes robust biofilms. Our study uncovers the role that VA plays in facilitating the attachment of A. baumannii cells to surfaces, a crucial step in biofilm formation. These findings provide valuable insights into a previously obscure catabolic pathway with significant clinical implications.
21 Oct 2023Submitted to Molecular Microbiology
21 Oct 2023Submission Checks Completed
21 Oct 2023Assigned to Editor
22 Oct 2023Reviewer(s) Assigned
17 Nov 2023Review(s) Completed, Editorial Evaluation Pending
18 Nov 2023Editorial Decision: Revise Minor